Article Versions Notes

Xu Y, Cai Q, Zhao C, Zhang W, Xu X, Lin H, Lin Y, Chen D, Lin S, Jia P, et al. Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation. Pharmaceuticals. 2025; 18(1):12. https://doi.org/10.3390/ph18010012

Xu, Yaoyao, Qiaoyan Cai, Chunyu Zhao, Weixiang Zhang, Xinting Xu, Haowei Lin, Yuxing Lin, Daxin Chen, Shan Lin, Peizhi Jia, and et al. 2025. "Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation" Pharmaceuticals 18, no. 1: 12. https://doi.org/10.3390/ph18010012

Xu, Y., Cai, Q., Zhao, C., Zhang, W., Xu, X., Lin, H., Lin, Y., Chen, D., Lin, S., Jia, P., Wang, M., Zhang, L., & Lin, W. (2025). Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation. Pharmaceuticals, 18(1), 12. https://doi.org/10.3390/ph18010012